News
With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the ...
In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria ...
AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency ...
Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...
Pfizer and Astellas Pharma have shared positive top-line results from a late-stage study of their androgen receptor ...
We are thrilled to announce that Medscape Education has been honored with the SILVER Award in the Patient Education ...
Novartis and Matchpoint Therapeutics have entered into a partnership worth $1bn to develop oral inhibitors for inflammatory ...
AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...
Rain Free Days® is a free migraine support app created by Teva, 11 London, and the migraine community. It helps users track ...
LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...
Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The ...
Eli Lilly and Almirall’s Ebglyss (lebrikizumab) has been shown to significantly improve the signs and symptoms of atopic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results